Fresh or Frozen Grafts for Allogeneic Stem Cell Transplantation: Conceptual Considerations and a Survey on the Practice During the COVID-19 Pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working...

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2023 Sep 6

PMID 37673982

Authors

N Worel

P Ljungman

I C M Verheggen

J D Hoogenboom

N S Knelange

D-J Eikema

I Sanchez-Ortega

C Riillo

I Centorrino

D Averbuch

C Chabannon

R de la Camara

J Kuball

A Ruggeri

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has had a significant impact on medical practices, including the delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant centers have made changes to their procedures, including an increased use of cryopreservation for allogeneic haematopoietic progenitor cell (HPC) grafts. The use of cryopreserved grafts for allogeneic HCT has been reviewed and analysed in terms of potential benefits and drawbacks based on existing data on impact on cell subsets, hematological recovery, and clinical outcomes of approximately 2000 patients from different studies. A survey of European Society for Blood and Marrow Transplantation centers was also conducted to assess changes in practice during the pandemic and any unnecessary burdens on HPC donors. Before the pandemic, only 7.4% of transplant centers were routinely cryopreserving HPC products, but this percentage increased to 90% during the pandemic. The results of this review and survey suggest that cryopreservation of HPC grafts is a viable option for allogeneic HCT in certain situations, but further research is needed to determine long-term effects and ethical discussions are required to balance the needs of donors and patients when using frozen allografts.

Citing Articles

Schmidt A Curr Opin Hematol. 2024; 31(6):251-260.

PMID: 39046928 PMC: 11426981. DOI: 10.1097/MOH.0000000000000835.

The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic.

Strzelec A, Gawlik-Rzemieniewska N, Klima A, Panek K, Helbig G In Vivo. 2024; 38(3):1271-1277.

PMID: 38688614 PMC: 11059856. DOI: 10.21873/invivo.13565.

Pros and Cons of Cryopreserving Allogeneic Stem Cell Products.

Valentini C, Pellegrino C, Teofili L Cells. 2024; 13(6.

PMID: 38534396 PMC: 10968795. DOI: 10.3390/cells13060552.

References

Faulkner J, OBrien W, McGrane B, Wadsworth D, Batten J, Askew C . Physical activity, mental health and well-being of adults during initial COVID-19 containment strategies: A multi-country cross-sectional analysis. J Sci Med Sport. 2020; 24(4):320-326. PMC: 7711171. DOI: 10.1016/j.jsams.2020.11.016. View

Al Hamed R, Bazarbachi A, Malard F, Harousseau J, Mohty M . Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019; 9(4):44. PMC: 6453900. DOI: 10.1038/s41408-019-0205-9. View

Mohty M, Hubel K, Kroger N, Aljurf M, Apperley J, Basak G . Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014; 49(7):865-72. DOI: 10.1038/bmt.2014.39. View

Czerw T, Labopin M, Schmid C, Cornelissen J, Chevallier P, Blaise D . High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched.... Oncotarget. 2016; 7(19):27255-66. PMC: 5053647. DOI: 10.18632/oncotarget.8463. View

Czerw T, Iacobelli S, Malpassuti V, Koster L, Kroger N, Robin M . Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant. 2021; 57(2):261-270. DOI: 10.1038/s41409-021-01540-2. View

Blazar B, Hill G, Murphy W . Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD. Nat Rev Clin Oncol. 2020; 17(8):475-492. PMC: 7901860. DOI: 10.1038/s41571-020-0356-4. View

Cox J, Ferrari G, Kalams S, Lopaczynski W, Oden N, DSouza M . Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res Hum Retroviruses. 2005; 21(1):68-81. DOI: 10.1089/aid.2005.21.68. View

Ramachandran H, Laux J, Moldovan I, Caspell R, Lehmann P, Subbramanian R . Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells. 2014; 1(3):313-24. PMC: 3901099. DOI: 10.3390/cells1030313. View

Li Y, Mateu E, Diaz I . Impact of Cryopreservation on Viability, Phenotype, and Functionality of Porcine PBMC. Front Immunol. 2021; 12:765667. PMC: 8666977. DOI: 10.3389/fimmu.2021.765667. View

10.

Panch S, Srivastava S, Elavia N, McManus A, Liu S, Jin P . Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics. Mol Ther. 2019; 27(7):1275-1285. PMC: 6612799. DOI: 10.1016/j.ymthe.2019.05.015. View

11.

Pi C, Hornberger K, Dosa P, Hubel A . Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants. Cytotherapy. 2020; 22(5):291-300. PMC: 7682753. DOI: 10.1016/j.jcyt.2020.01.013. View

12.

Xu H, Cao W, Huang L, Xiao M, Cao Y, Zhao L . Effects of cryopreservation on chimeric antigen receptor T cell functions. Cryobiology. 2018; 83:40-47. DOI: 10.1016/j.cryobiol.2018.06.007. View

13.

Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery C, Silvestri G . Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods. 2003; 278(1-2):145-55. DOI: 10.1016/s0022-1759(03)00202-3. View

14.

Luo Y, Wang P, Liu H, Zhu Z, Li C, Gao Y . The state of T cells before cryopreservation: Effects on post-thaw proliferation and function. Cryobiology. 2017; 79:65-70. DOI: 10.1016/j.cryobiol.2017.08.008. View

15.

Duchez P, Chevaleyre J, Brunet De La Grange P, Vlaski M, Boiron J, Wouters G . Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells. Transfusion. 2012; 53(9):2012-9. DOI: 10.1111/trf.12015. View

16.

Berens C, Heine A, Muller J, Held S, Mayer K, Brossart P . Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products. Cytotherapy. 2016; 18(10):1325-31. DOI: 10.1016/j.jcyt.2016.06.014. View

17.

Kaushal R, Jahan S, McGregor C, Pineault N . Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts. Cytotherapy. 2021; 24(3):272-281. DOI: 10.1016/j.jcyt.2021.09.002. View

18.

Pollock K, Yu G, Moller-Trane R, Koran M, Dosa P, McKenna D . Combinations of Osmolytes, Including Monosaccharides, Disaccharides, and Sugar Alcohols Act in Concert During Cryopreservation to Improve Mesenchymal Stromal Cell Survival. Tissue Eng Part C Methods. 2016; 22(11):999-1008. PMC: 5125256. DOI: 10.1089/ten.TEC.2016.0284. View

19.

Matsumura K, Hyon S . Polyampholytes as low toxic efficient cryoprotective agents with antifreeze protein properties. Biomaterials. 2009; 30(27):4842-9. DOI: 10.1016/j.biomaterials.2009.05.025. View

20.

Li R, Hornberger K, Dutton J, Hubel A . Cryopreservation of Human iPS Cell Aggregates in a DMSO-Free Solution-An Optimization and Comparative Study. Front Bioeng Biotechnol. 2020; 8:1. PMC: 6987262. DOI: 10.3389/fbioe.2020.00001. View